SCHEMBL7559161

SCHEMBL7559161

CC(C)(C)C(NC(=O)c1ccc(Cl)cc1)(Nc1c(Nc2cncc(C(F)(F)F)c2)c(=O)c1=O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS2R14 Q9NYV8 1/20 0.43
RXFP1 Q9HBX9 1/20 0.39
MAPKAPK2 P49137 1/20 0.39
DDR1 Q08345 2/20 0.38
EPHB2 P29323 1/20 0.37
DDR2 Q16832 1/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
GAA P10253 1/20 0.37
USP36 Q9P275 1/20 0.36
P2RX1 P51575 1/20 0.35
CXCR2 P25025 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
SLC22A6 Q4U2R8 1/20 0.35
SLC22A8 Q8TCC7 1/20 0.35
SLC22A12 Q96S37 1/20 0.35
SLC22A11 Q9NSA0 1/20 0.35
RHOC P08134 1/20 0.35
RHOA P61586 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6989035 0.77 KCNJ11 (0.46) TAS2R14RXFP1DDR1LMNAUSP36
SCHEMBL6989037 0.76 DDR1 (0.43) TAS2R14RXFP1DDR1LMNAPOLB
SCHEMBL6982554 0.76 TAS2R14 (0.39) TAS2R14RXFP1MAPKAPK2DDR1LMNA
SCHEMBL7559454 0.69 TAS2R14 (0.37) TAS2R14DDR1GAAUSP36CYP3A4
SCHEMBL7559839 0.68 RHOC (0.39) DDR1LMNAGAAUSP36RHOC
SCHEMBL30728660 0.67 P2RX1 (0.70) TAS2R14RXFP1LMNAGAAP2RX1
SCHEMBL7092768 0.64 TAS2R14 (0.47) TAS2R14CYP3A4CYP2C9SLC22A6SLC22A8
SCHEMBL3835811 0.63 POLB (0.56) LMNAPOLBGAAUSP36
SCHEMBL27070948 0.62 NAMPT (0.56) RXFP1DDR1EPHB2DDR2USP36
SCHEMBL30728722 0.62 NAMPT (0.56) RXFP1DDR1EPHB2DDR2USP36

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020165264-A1 Aminal diones as potassium channel openers ABBOTT LABORATORIES 2002-11-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020165264-A1 Aminal diones as potassium channel openers KCNJ2, KCNJ11, KCNH1 TAS2R14 2840/4885RXFP1 2600/4885MAPKAPK2 2283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.